Alterola Biotech, Inc.
ABTI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7,121 | $11,541 | $35,180 | $40,352 |
| - Cash | $9 | $37 | $9 | $13 |
| + Debt | $1,551 | $1,373 | $1,415 | $1,293 |
| Enterprise Value | $8,663 | $12,877 | $36,586 | $41,632 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$123 | -$576 | $127 | -$541 |
| % Margin | – | – | – | – |
| Net Income | -$123 | -$719 | $180 | -$535 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.001 | 0 | -0.001 |
| % Growth | 77.8% | -550% | 128.6% | – |
| Operating Cash Flow | -$122 | -$75 | $117 | -$793 |
| Capital Expenditures | $0 | -$19 | $0 | $0 |
| Free Cash Flow | -$122 | -$94 | $117 | -$793 |